Home › Crohn's Disease › Texas › Houston
Pag-aaral pangklinika para sa Crohn's Disease sa Houston, TX
Isang pag-aaral para sa Crohn's Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Nagre-recruitPhase 3
- Baylor College of Medicine Medical Center ( Site 5020), Houston
- Michael E. DeBakey VA Medical Center ( Site 5086), Houston
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Nagre-recruitPhase 2
- Integrity Advanced Therapeutics /ID# 283871, Houston
- Novel Research - Bellaire /ID# 280925, Bellaire · 7 mi ang layo
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Nagre-recruitPhase 4
- Kelsey Research Foundation, Houston
- MedCare Pharma LLC, Houston
- Spring Clinical Research, Houston
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Nagre-recruitPhase 2
- Houston Methodist Hospital /ID# 265533, Houston
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2/3
- Victorium Clinical Research, Houston
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2
- Novel Research, LLC, Bellaire · 7 mi ang layo
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
- UT MD Anderson Cancer Center, Houston
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2
- The University of Texas Health Science Center at Houston, Houston
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Nagre-recruitPhase 4
- The University of Texas Health Science Center at Houston, Houston
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
Nagre-recruitObservasyonal na pag-aaral
- BAMC, Houston
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Nagre-recruit
- Baylor College of Medicine, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Nagre-recruitObservasyonal na pag-aaral
- M D Anderson Cancer Center, Houston
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Nagre-recruitPhase 3
- Texas Children's Hospital - Baylor - PIN, Houston
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Nagre-recruitPhase 3
- Texas Children's Hospital, Houston
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Nagre-recruitPhase 2
- Houston Methodist Hospital, Houston
- Novel Research, LLC, Bellaire · 7 mi ang layo
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Nagre-recruitPhase 2
- Mirador Therapeutics Selected Site, Houston
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Nagre-recruitPhase 4
- Houston Methodist Hospital, Houston
Pag-aaral para sa Crohn's Disease sa ibang lungsod
- New York City, NY35 pag-aaral
- Cleveland, OH19 pag-aaral
- St. Louis, MO19 pag-aaral
- Boston, MA19 pag-aaral
- Miami, FL19 pag-aaral
- Orlando, FL17 pag-aaral
- Atlanta, GA17 pag-aaral
- Tyler, TX16 pag-aaral
- San Diego, CA15 pag-aaral
- San Antonio, TX15 pag-aaral
- Los Angeles, CA15 pag-aaral
- Philadelphia, PA13 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer145 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)121 pag-aaral
- Metastatic Cancer104 pag-aaral
- Colorectal Cancer102 pag-aaral
- Kanser sa Ovary89 pag-aaral
- Acute Myeloid Leukemia85 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate76 pag-aaral
- Kanser ng Endometrium68 pag-aaral
- Kanser sa Pancreas61 pag-aaral
- Melanoma59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.